However, some forms of HR deficiency in BRCA-associated cancer types, such as germline BRCA1 mutation in OV and BRCA2 mutation in BRCA, showed limited associations with TMB or neoantigen loads, and also failed to demonstrate improved survival after immunotherapy in the limited clinical cohorts available for this study. Here, BRCA1 is linked to cancer.